drugset / Trial / NCT06772792
A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Alendronate in Healthy Adult Participants (MK-0616-027)
RandomizedCrossoverOpen-labelBasic science
Summary
The goal of this study is to learn what happens to a single dose of alendronate over time in a healthy participant's body when the participant is given a single dose of enlicitide decanoate. Researchers want to learn how safe and tolerable is the co-administration of enlicitide decanoate and alendronate.
Timeline
- Start
- 2024-04-23
- Primary completion
- 2024-06-21
- Completion
- 2024-06-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alendronic Acid | Small molecule | — | Oral |
| Subject | Enlicitide Decanoate | Unknown | — | Oral |
Indications
No indication recorded.